"And remember these are associations, not causations, so it's not to say that GLP-1 use causes NAION or worsening retinopathy, but their use is associated with these conditions." "From an ophthalmologic standpoint, these findings underscore the importance of baseline and follow-up eye examinations for patients starting GLP-1 therapy, especially those with pre-existing retinal or optic nerve risk factors." The expert added that while the benefits of GLP-1 medications in reducing cardiovascular and metabolic risks are "substantial," patients should be counseled on potential visual side effects, and "any sudden visual symptoms should prompt immediate ophthalmic referral." For more Health articles, visit www.foxnews.com/health Novo Nordisk, maker of Ozempic and Wegovy, provided the following statement when contacted by Fox News Digital
The longer needles create more significant micro-injury requiring extended recovery
Growth Hormone Peptides (CJC-1295, Ipamorelin, Sermorelin) These peptides stimulate your body's natural production of growth hormone, which plays a role in tissue repair, muscle recovery, and overall healing
In those cases, the body triggers an inflammatory response to start healing
The most evidence-backed approach is testing for and correcting specific deficiencies